Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Puma Biotechnology (PBYI) Change in Account Payables (2017 - 2025)

Puma Biotechnology's Change in Account Payables history spans 9 years, with the latest figure at -$1.3 million for Q4 2025.

  • For Q4 2025, Change in Account Payables rose 33.5% year-over-year to -$1.3 million; the TTM value through Dec 2025 reached -$453000.0, up 67.17%, while the annual FY2025 figure was -$453000.0, 67.17% up from the prior year.
  • Change in Account Payables reached -$1.3 million in Q4 2025 per PBYI's latest filing, down from $962000.0 in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $8.9 million in Q3 2021 to a low of -$8.9 million in Q4 2021.
  • Average Change in Account Payables over 5 years is -$351000.0, with a median of -$45000.0 recorded in 2021.
  • The largest YoY upside for Change in Account Payables was 1067.02% in 2021 against a maximum downside of 1863.05% in 2021.
  • A 5-year view of Change in Account Payables shows it stood at -$8.9 million in 2021, then increased by 4.35% to -$8.5 million in 2022, then skyrocketed by 121.54% to $1.8 million in 2023, then plummeted by 209.41% to -$2.0 million in 2024, then soared by 33.5% to -$1.3 million in 2025.
  • Per Business Quant, the three most recent readings for PBYI's Change in Account Payables are -$1.3 million (Q4 2025), $962000.0 (Q3 2025), and -$602000.0 (Q2 2025).